NCT04474821 2026-01-12
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
Mayo Clinic
Phase 4 Completed
Clinical Trials
13 trialsNCT04982614 2025-08-24
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
Phase 4 Completed
NCT01824537 2025-03-19
TRAP-HPV
McGill University
Phase 4 Completed
NCT04590521 2024-02-01
HPV Vaccine Immunity in High-risk Women
Murdoch Childrens Research Institute
Phase 4 Completed
NCT05435209 2023-11-29
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
University of Washington
Phase 4 Completed
NCT05426148 2022-06-29
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
Phase 4 Completed
NCT04459221 2022-03-02
PROM SSCOL
Centre Hospitalier Universitaire de la Réunion
Phase 4 Completed
NCT01101750 2021-01-05
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Medstar Health Research Institute
Phase 4 Completed
NCT00956553 2020-10-01
HPV CSP01
Public Health England
Phase 4 Completed
NCT01031069 2020-07-21
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
GlaxoSmithKline
Phase 4 Completed
NCT00534638 2019-11-15
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents
GlaxoSmithKline
Phase 4 Completed
NCT00925288 2012-10-11
Girasol
Johns Hopkins Bloomberg School of Public Health
Phase 4 Completed
NCT01571141 2012-04-19
Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection
AGUNCO Obstetrics and Gynecology Centre
Phase 4 Completed